LYNN BAXTER
Board of Directors member
Lynn Baxter is Senior Vice President, Head of Europe Commercial at GSK since November 2024. In this critical leadership role, she is responsible for commercialising a portfolio of medicines and vaccines with annual sales of around £6 billion and operations in over 30 countries.
Previous to this, Lynn was Senior Vice President, Head of North America at ViiV Healthcare. Under her leadership, the team delivered strong performance with sustained double-digit growth, successfully executing four major launches including oral two-drug regimens and long-acting injectables for HIV treatment and prevention. These paradigm-shifting launches required changing mindsets and embedding industry leading go-to-market and provider operating models to ensure ViiV’s innovative medicines deliver results for the business and reach the people who need them.
Prior to this, Lynn was Senior Vice President, Head of Global Vaccines Commercial at GSK, overseeing global strategy for a portfolio and pipeline of over 30 vaccines. She has also served as General Manager for GSK Philippines and held commercial leadership roles in Emerging Markets and Asia Pacific, China, and global marketing.
Before joining GSK in 2009, Lynn progressed through positions of increasing seniority at Roche Pharmaceuticals and Merck Sharp & Dohme.
Lynn brings a proven track record of impact over almost three decades of global experience across pharmaceuticals and vaccines, having held senior leadership roles in the USA, Europe, and Asia.
YOU MAY ALSO BE INTERESTED IN
Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.
Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.
NP-GBL-HVX-COCO-220025 August 2025
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
